Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q2 2019 · 10-Q
Revenue$3.02M$3.02M+33.4% vs Q2 2018 Net Income-$351.42K-$351.42KN/M vs Q2 2018 EPS Diluted-$0.15-$0.15N/M vs Q2 2018 Gross Profit$2,682,660+27.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived-$803,421N/M Free Cash Flowderived-$822,233N/M Margins · derivedGross margin88.9%−4.1 pt vs Q2 2018
Operating margin-10.7%−12.1 pt vs Q2 2018
Net margin-11.6%−13.0 pt vs Q2 2018
ended Jun 30, 2019 · filed Aug 14, 2019 · 45 d after period end